INTELLIGENT BIO SOLUTIONS INC. (INBS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 600K 1.2M 1.8M Q4 '21: 1.6M Q2 '22: 177.8K Q3 '22: 192.5K Q4 '22: 66.9K Q1 '23: 311.3K Q2 '23: 356.7K Q3 '23: 457.1K Q4 '23: 443.1K Q1 '24: 796.1K Q2 '24: 764.1K Q3 '24: 823.8K Q4 '24: 727.8K Q1 '25: 872.3K Q2 '25: 607.5K Q3 '25: 728.9K Q4 '25: 843.9K Q1 '26: 1.1M Q2 '26: 896.8K Q3 '26: 1.1M Q4 '26: 1.1M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Gross Profit Quarterly

0 300K 600K 900K Q2 '23: 244K Q3 '23: 33K Q4 '23: 49.6K Q1 '24: 232.3K Q2 '24: 199.2K Q3 '24: 178.5K Q4 '24: 815.6K Q1 '25: 346.8K Q2 '25: 223.1K Q3 '25: 341.4K Q4 '25: 335.6K Q1 '26: 518.3K Q2 '26: 459.7K Q3 '26: 535.4K Q4 '26: 536.6K Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '22: -1.4M Q2 '22: -3.5M Q3 '22: -1.3M Q4 '22: -2.1M Q1 '23: -1.2M Q2 '23: -2.1M Q3 '23: -6.5M Q4 '23: -2.7M Q1 '24: -2.5M Q2 '24: -2M Q3 '24: -3M Q4 '24: -2.8M Q1 '25: -2.7M Q2 '25: -2.3M Q3 '25: -2.6M Q4 '25: -3.1M Q1 '26: -3M Q2 '26: -2.6M Q3 '26: -2.9M Q4 '26: -4M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '22: -1.4M Q2 '22: -3.5M Q3 '22: -1.3M Q4 '22: -2.1M Q1 '23: -1.2M Q2 '23: -420.6K Q3 '23: -6.3M Q4 '23: -2.7M Q1 '24: -2.4M Q2 '24: -2M Q3 '24: -3M Q4 '24: -2.8M Q1 '25: -2.7M Q2 '25: -2.2M Q3 '25: -2.5M Q4 '25: -3.1M Q1 '26: -3M Q2 '26: -2.7M Q3 '26: -2.9M Q4 '26: -3.9M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue Quarterly

-250K 0 250K 500K 750K Q2 '23: 112.6K Q3 '23: 424K Q4 '23: 393.6K Q1 '24: 563.8K Q2 '24: 564.8K Q3 '24: 645.3K Q4 '24: -87.7K Q1 '25: 525.5K Q2 '25: 384.4K Q3 '25: 387.5K Q4 '25: 508.3K Q1 '26: 593.5K Q2 '26: 437K Q3 '26: 525.4K Q4 '26: 609.2K Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '22: 83K Q2 '22: -1.4M Q3 '22: -292.2K Q4 '22: -1.7M Q1 '23: -1.9M Q2 '23: -2.4M Q3 '23: -2.5M Q4 '23: -584.3K Q1 '24: -1.3M Q2 '24: -2.9M Q3 '24: -2.4M Q4 '24: -2.9M Q1 '25: -2.4M Q2 '25: -2.3M Q3 '25: -2.8M Q4 '25: -2.2M Q1 '26: -2.8M Q2 '26: -1.6M Q3 '26: -4.3M Q4 '26: -3.2M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -2.4M Q3 '25: -2.8M Q1 '26: -2.9M Q2 '26: -1.6M Q3 '26: -4.3M Q4 '26: -3.2M Q3 '24 Q3 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q3 '21: 11.8M Q1 '22: 14M Q2 '22: 744.1K Q3 '22: 744.5K Q1 '23: 744.5K Q2 '23: 75.7K Q3 '23: 92.4K Q1 '24: 194.2K Q2 '24: 949.7K Q3 '24: 2.1M Q1 '25: 3.8M Q2 '25: 453.6K Q3 '25: 577.2K Q1 '26: 8.5M Q2 '26: 950.8K Q3 '26: 1.6M Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 Q4 '20: -0.37 Q1 '21: -0.40 Q2 '21: -0.41 Q3 '21: -0.67 Q4 '21: -0.66 Q1 '22: -0.64 Q2 '23: -11.76 Q3 '23: -78.64 Q4 '23: -98.81 Q1 '24: -109.67 Q2 '24: -106.18 Q3 '24: -38.94 Q4 '25: -14.19 Q1 '26: -13.84 Q2 '26: -11.70 Q3 '26: -9.09 Q4 '26: -5.87 Q1 '21 Q4 '21 Q3 '23 Q2 '24 Q1 '26 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.